Clinical Trial: Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept(R) 5 mg and Aricept(R) 10 mg Film-coated Tablet in Healthy Subjects

U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799090) titled 'Pharmacokinetic Study of GB-5001A 280 mg Long Acting Injection, in Comparison With the Comparator Drug Aricept(R) 5 mg and Aricept(R) 10 mg Film-coated Tablet in Healthy Subjects' on Aug. 19.

Brief Summary: This study is to find out whether the bioavailability of GB-5001A 280 mg Injection is compared to the comparator drug of Aricept(R) 5 mg and Aricept(R) 10 mg which are Film-Coated Tablet when administered in healthy subjects. Also to monitor the adverse events and to ensure the safety of the subjects.

Study Start Date: Aug. 12, 2025

Study Type: INTERVENTIONAL

Condition: Bioavailability Study on Healthy Volunteers

Interventio...